These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27515672)

  • 21. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
    Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center.
    Huang HC; Huang YS; Wu JC; Tsay SH; Huo TI; Wang YJ; Lo JC; Chen CY; Li CP; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):563-9. PubMed ID: 12636201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    Banerjee S; Rahhal R; Bishop WP
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
    Ytting H; Larsen FS
    Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M;
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.
    Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Morimoto H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Yano K; Komori A; Yatsuhashi H; Nakamura M; Ishibashi H
    J Gastroenterol; 2011 Jan; 46 Suppl 1():56-62. PubMed ID: 21042923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
    Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
    Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
    Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
    Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural history of autoimmune hepatitis presenting with jaundice.
    Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.
    Anastasiou OE; Dogan-Cavus B; Kucukoglu O; Baba H; Kahraman A; Gerken G; Schramm C; Canbay A
    Digestion; 2018; 98(2):104-111. PubMed ID: 29698940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of autoimmune hepatitis].
    Verwer BJ; Bouma G; Bloemena E; Schreuder TC; Mulder CJ; van Nieuwkerk KM
    Ned Tijdschr Geneeskd; 2009; 153():A247. PubMed ID: 19900315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.